Jim Tananbaum has an interdisciplinary approach to life and to professional pursuits in the healthcare economy. Tananbaum has nearly 25 years of diversified entrepreneurial experience in healthcare investment. In April 2017 he was reported by Inc42 to be named Forbes’ Midas List of top tech investors for the third straight year. These persons are noted to create outstanding value for their investors.
Tananbaum is the founder and Chief Executive Officer of Foresite Capital, which is noted to be a “private equity firm.” Foresite Capital provides funding, information and networking opportunity to men and women who are projected to be noted leaders in healthcare. Tananbaum utilizes his past education, career experience and collaboration with others in creating a one-of-a-kind investment platform on which Foresite Capital is largely based.
Academically, Tananbaum has cultivated interdisciplinary pathways in computer science, the traditional science and business. He has an MD and MBA from Harvard University; an MS from the Massachusetts Institute of Technology; and BS/BSEE from Yale University. His professional credentials include co-founding Theravance Inc and Geltex Pharmaceuticals. Both of these companies have produced substantial six-figure dividends in the healthcare economy, respectively. Today, Foresite Capital has investments in over 70 healthcare franchise covering diagnostics, medical services and bio-pharmaceuticals.
Tananbaum is noted on “Ideamensch” to have had influence from key academicians that have aided in establishing his passion toward a multidisciplinary approach to healthcare investment. Names include Rick Clausner, NCI; George Whitesides, Harvard University; and Roy Vagelos, Merck and Theravance. Tananbaum foresees interdisciplinary collaboration to become more common in the not-to-distant future in numerous fields besides healthcare; this will further enhance learning and product development as we know it today.
Foresite Capital selects investment opportunities from researching published information focused on healthcare need. Then, finding the “thought leaders” endeavoring to address those identified needs and meld them with the opportunity are where the investment strategy comes to life. For Tananbaum, the love of learning and “engaging the smartest effective persistent leaders in healthcare” are what lie at the heart of his profession as an entrepreneurial healthcare leader.